Intravenous Exosome–Liposome Hybrid Vesicles (Hybrosomes) as an Adjunct to Standard Care in Cats with Chronic Kidney Disease: An Open-Label, Uncontrolled Pilot Case Series of Ten Cats

Chronic kidney disease (CKD) is a leading cause of feline morbidity, and few interventions beyond dietary and supportive care alter its course. Hybrosomes (the manufacturer’s designation for extracellular vesicle [EV]–liposome hybrid vesicles) are a proposed cell-free renal therapy with no clinical data in cats. We conducted an open-label, uncontrolled pilot case series of ten client-owned cats with IRIS stage 2–4 CKD (staged by serum creatinine, Cr) that received four intravenous hybrosome infusions, administered once weekly, each preceded by methylprednisolone sodium succinate, in addition to standard care that continued or adjusted fluid therapy. Blood urea nitrogen (BUN) and Cr were measured weekly to week 4; renal Doppler indices and left ventricular global longitudinal strain (LV GLS) were assessed at baseline and week 4 in seven cats. For the two principal renal outcomes (baseline to week 4, Holm-adjusted across the two outcomes), median BUN decreased from 94 to 47 mg/dL (adjusted p = 0.012) and median Cr from 4.6 to 2.7 mg/dL (adjusted p = 0.020); in exploratory weekly comparisons adjusted across four time points, the week-4 Cr change had an adjusted p of 0.078. Six cats showed a reduction in serum Cr of ≥25% and six shifted to a lower creatinine-based IRIS category, whereas none shifted to a higher category. However, the rapid early falls in two cats (cats 1 and 3) may have reflected a prerenal or acute-on-chronic component. After excluding these cats, the decrease in serum Cr was no longer statistically significant (n = 8, p = 0.078). LV GLS became numerically more negative in all seven cats (unadjusted p = 0.016), but the change was small in six of the seven cats (0.7–2.0 percentage points) and the 95% confidence interval of the mean difference included zero. Four cats developed transient nausea or salivation during or after infusion; isolated haematological abnormalities (thrombocytopenia in two cats, leukocytosis in one and falls in haemoglobin in several) were also recorded and could not be attributed to, or excluded from, the treatment. Because the series was uncontrolled and standard therapy, including fluid therapy and methylprednisolone sodium succinate premedication, were continued, these findings are hypothesis-generating and do not establish efficacy; placebo-controlled trials with longer follow-up would be needed to test efficacy and safety.

Authors

Institutions

Publication Details

Journal
Veterinary Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/vetsci13111244
Primary Topic
Veterinary Medicine and Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intravenous Exosome–Liposome Hybrid Vesicles (Hybrosomes) as an Adjunct to Standard Care in Cats with Chronic Kidney Disease: An Open-Label, Uncontrolled Pilot Case Series of Ten Cats

Serli Canikyan, Zeki Yılmaz, Yaren Kul, Lina Hamabe et al.
Veterinary Sciences
Veterinary Medicine and Surgery
article

Intravenous Exosome–Liposome Hybrid Vesicles (Hybrosomes) as an Adjunct to Standard Care in Cats with Chronic Kidney Disease: An Open-Label, Uncontrolled Pilot Case Series of Ten Cats

Serli Canikyan, Zeki Yılmaz, Yaren Kul, Lina Hamabe, Sebnem Unluisler, Ceren Duyan, Tuğba Varlik, Didem Algan, Kübra Nur Der
article en

Abstract

Chronic kidney disease (CKD) is a leading cause of feline morbidity, and few interventions beyond dietary and supportive care alter its course. Hybrosomes (the manufacturer’s designation for extracellular vesicle [EV]–liposome hybrid vesicles) are a proposed cell-free renal therapy with no clinical data in cats. We conducted an open-label, uncontrolled pilot case series of ten client-owned cats with IRIS stage 2–4 CKD (staged by serum creatinine, Cr) that received four intravenous hybrosome infusions, administered once weekly, each preceded by methylprednisolone sodium succinate, in addition to standard care that continued or adjusted fluid therapy. Blood urea nitrogen (BUN) and Cr were measured weekly to week 4; renal Doppler indices and left ventricular global longitudinal strain (LV GLS) were assessed at baseline and week 4 in seven cats. For the two principal renal outcomes (baseline to week 4, Holm-adjusted across the two outcomes), median BUN decreased from 94 to 47 mg/dL (adjusted p = 0.012) and median Cr from 4.6 to 2.7 mg/dL (adjusted p = 0.020); in exploratory weekly comparisons adjusted across four time points, the week-4 Cr change had an adjusted p of 0.078. Six cats showed a reduction in serum Cr of ≥25% and six shifted to a lower creatinine-based IRIS category, whereas none shifted to a higher category. However, the rapid early falls in two cats (cats 1 and 3) may have reflected a prerenal or acute-on-chronic component. After excluding these cats, the decrease in serum Cr was no longer statistically significant (n = 8, p = 0.078). LV GLS became numerically more negative in all seven cats (unadjusted p = 0.016), but the change was small in six of the seven cats (0.7–2.0 percentage points) and the 95% confidence interval of the mean difference included zero. Four cats developed transient nausea or salivation during or after infusion; isolated haematological abnormalities (thrombocytopenia in two cats, leukocytosis in one and falls in haemoglobin in several) were also recorded and could not be attributed to, or excluded from, the treatment. Because the series was uncontrolled and standard therapy, including fluid therapy and methylprednisolone sodium succinate premedication, were continued, these findings are hypothesis-generating and do not establish efficacy; placebo-controlled trials with longer follow-up would be needed to test efficacy and safety.

Veterinary SciencesVol. 13(11)
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Tokyo University of Agriculture and Technology (JP)
Veterinary Medicine and Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon